{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:11:21Z","timestamp":1744431081047,"version":"3.40.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This meta-analysis investigates the association between acute lymphoblastic leukemia (ALL) susceptibility and <jats:italic>IKZF1<\/jats:italic> gene SNPs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Utilizing EMBASE, PubMed, and other databases, the study evaluated methodological quality through the Newcastle\u2013Ottawa Scale (NOS) scoring and Hardy\u2013Weinberg Equilibrium (HWE) value. The present meta-analysis used Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. Review Manager 5.4 software was employed for data analysis, emphasizing genetic variants' significance (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Visualizations were achieved using funnel and Circos plots.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A significant association was found between rs4132601 and ALL across genetic models, contrasting with the non-significant correlation for rs11978267. The findings underscore the complex interplay of genetic factors in ALL susceptibility, particularly related to <jats:italic>IKZF1<\/jats:italic> SNPs. Ethnicity emphasizes the importance of diverse population considerations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This meta-analysis highlights the significance of rs4132601 in ALL's genetic foundation, suggesting potential advancements in diagnostics. The lack of correlation for rs11978267 highlights the complexity of its genetic association. Future studies should prioritize larger, diverse samples for a comprehensive understanding and improved strategies for ALL diagnoses and treatments.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s43046-025-00274-2","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T13:25:01Z","timestamp":1744377901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the impact of IKZF1 SNPs rs4132601 and rs11978267 on acute lymphoblastic leukemia: a comprehensive meta-analysis"],"prefix":"10.1186","volume":"37","author":[{"given":"Sheena Mariam","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jethendra Kumar","family":"Muruganantham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen Kumar Chandra","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. K.","family":"Iyshwarya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9307-5428","authenticated-orcid":false,"given":"Ramakrishnan","family":"Veerabathiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"274_CR1","doi-asserted-by":"publisher","unstructured":"Janani, G., Girigoswami, A., & Girigoswami, K. Advantages of nanomedicine over the conventional treatment in Acute myeloid leukemia. J Biomater Sci Polym. 2024;415\u2013441. https:\/\/doi.org\/10.1080\/09205063.2023.2294541.","DOI":"10.1080\/09205063.2023.2294541"},{"key":"274_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1745-6673-8-14","volume":"8","author":"I Polychronakis","year":"2013","unstructured":"Polychronakis I, Dounias G, Makropoulos V, Riza E, Linos A. Work-related leukemia: a systematic review. J Occup Med Toxicol. 2013;8:14. https:\/\/doi.org\/10.1186\/1745-6673-8-14.","journal-title":"J Occup Med Toxicol"},{"key":"274_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.5599\/admet.2013","volume":"11","author":"G Janani","year":"2023","unstructured":"Janani G, Girigoswami A, Girigoswami K. Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia. ADMET DMPK. 2023;11:499\u2013511. https:\/\/doi.org\/10.5599\/admet.2013.","journal-title":"ADMET DMPK"},{"key":"274_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937\u201351. https:\/\/doi.org\/10.1182\/blood-2009-03-209262.","journal-title":"Blood"},{"issue":"1","key":"274_CR5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s11033-020-06073-3","volume":"48","author":"TC Fujita","year":"2021","unstructured":"Fujita TC, Sousa-Pereira N, Amarante MK, Watanabe MAE. Acute lymphoid leukemia etiopathogenesis. Mol Biol Rep. 2021;48(1):817\u201322. https:\/\/doi.org\/10.1007\/s11033-020-06073-3.","journal-title":"Mol Biol Rep"},{"key":"274_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100677","volume":"44","author":"S Vairy","year":"2020","unstructured":"Vairy S, Tran TH. IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly. Blood Rev. 2020;44: 100677. https:\/\/doi.org\/10.1016\/j.blre.2020.100677.","journal-title":"Blood Rev"},{"key":"274_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3324\/haematol.2017.185603","volume":"103","author":"R Marke","year":"2018","unstructured":"Marke R, van Leeuwen FN, Scheijen B. The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia. Haematologica. 2018;103:565\u201374. https:\/\/doi.org\/10.3324\/haematol.2017.185603.","journal-title":"Haematologica"},{"key":"274_CR8","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1101\/gad.816400","volume":"14","author":"BS Cobb","year":"2000","unstructured":"Cobb BS, Morales-Alcelay S, Kleiger G, Brown KE, Fisher AG, Smale ST. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev. 2000;14:2146\u201360. https:\/\/doi.org\/10.1101\/gad.816400.","journal-title":"Genes Dev"},{"key":"274_CR9","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.molimm.2011.03.006","volume":"48","author":"LB John","year":"2011","unstructured":"John LB, Ward AC. The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol. 2011;48:1272\u20138. https:\/\/doi.org\/10.1016\/j.molimm.2011.03.006.","journal-title":"Mol Immunol"},{"key":"274_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMoa0808253","volume":"360","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360:470\u201380. https:\/\/doi.org\/10.1056\/NEJMoa0808253.","journal-title":"N Engl J Med"},{"key":"274_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ng.430","volume":"41","author":"E Papaemmanuil","year":"2009","unstructured":"Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1006\u201310. https:\/\/doi.org\/10.1038\/ng.430.","journal-title":"Nat Genet."},{"key":"274_CR12","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.leukres.2011.07.034","volume":"35","author":"A Pastorczak","year":"2011","unstructured":"Pastorczak A, G\u00f3rniak P, Sherborne A, et al. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res. 2011;35:1534\u20136. https:\/\/doi.org\/10.1016\/j.leukres.2011.07.034.","journal-title":"Leuk Res."},{"key":"274_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1089\/gtmb.2017.0084","volume":"21","author":"B Al-Absi","year":"2017","unstructured":"Al-Absi B, Razif MFM, Noor SM, et al. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population. Genet Test Mol Biomarkers. 2017;21:592\u20139. https:\/\/doi.org\/10.1089\/gtmb.2017.0084.","journal-title":"Genet Test Mol Biomarkers"},{"key":"274_CR14","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1158\/1940-6207.CAPR-17-0121","volume":"10","author":"BA Lopes","year":"2017","unstructured":"Lopes BA, Barbosa TC, Souza BKS, et al. IKZF1 gene in childhood B-cell precursor acute lymphoblastic leukemia: interplay between genetic susceptibility and somatic abnormalities. Cancer Prev Res (Phila). 2017;10:738\u201344. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-17-0121.","journal-title":"Cancer Prev Res (Phila)"},{"key":"274_CR15","doi-asserted-by":"publisher","first-page":"9579","DOI":"10.1007\/s13277-016-4853-0","volume":"37","author":"G Bahari","year":"2016","unstructured":"Bahari G, Hashemi M, Naderi M, Taheri M. IKZF1 gene polymorphisms increased the risk of childhood acute lymphoblastic leukemia in an Iranian population. Tumour Biol. 2016;37:9579\u201386. https:\/\/doi.org\/10.1007\/s13277-016-4853-0.","journal-title":"Tumour Biol"},{"key":"274_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/08880018.2016.1161685","volume":"33","author":"H Gharbi","year":"2016","unstructured":"Gharbi H, Ben Hassine I, Soltani I, Safra I, Ouerhani S, Bel Haj Othmen H, Teber M, Farah A, et al. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence. Pediatr Hematol Oncol. 2016;33:157\u201367.","journal-title":"Pediatr Hematol Oncol."},{"key":"274_CR17","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3109\/10428194.2010.511356","volume":"51","author":"J Vijayakrishnan","year":"2010","unstructured":"Vijayakrishnan J, Sherborne AL, Sawangpanich R, Hongeng S, Houlston RS, Pakakasama S. Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leuk Lymphoma. 2010;51:1870\u20134. https:\/\/doi.org\/10.3109\/10428194.2010.511356.","journal-title":"Leuk Lymphoma."},{"key":"274_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12920-022-01325-6","volume":"15","author":"M Sattarzadeh Bardsiri","year":"2022","unstructured":"Sattarzadeh Bardsiri M, Zehtab S, Karami N, Farsinejad A, Ehsan M, Fatemi A. Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis. BMC Med Genomics. 2022;15:171. https:\/\/doi.org\/10.1186\/s12920-022-01325-6.","journal-title":"BMC Med Genomics"},{"key":"274_CR19","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3109\/10428194.2013.866661","volume":"55","author":"P G\u00f3rniak","year":"2014","unstructured":"G\u00f3rniak P, Pastorczak A, Zalewska-Szewczyk B, et al. Polymorphism in IKZF1 gene affects age at onset of childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2014;55:2174\u20138. https:\/\/doi.org\/10.3109\/10428194.2013.866661.","journal-title":"Leuk Lymphoma"},{"key":"274_CR20","first-page":"3989","volume":"17","author":"P Bhandari","year":"2016","unstructured":"Bhandari P, Ahmad F, Mandava S, Das BR. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India. Asian Pac J Cancer Prev. 2016;17:3989\u201395.","journal-title":"Asian Pac J Cancer Prev"},{"key":"274_CR21","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1182\/blood-2009-09-241513","volume":"115","author":"RB Prasad","year":"2010","unstructured":"Prasad RB, Hosking FJ, Vijayakrishnan J, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood. 2010;115:1765\u20137. https:\/\/doi.org\/10.1182\/blood-2009-09-241513.","journal-title":"Blood."},{"key":"274_CR22","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.3324\/haematol.2013.090720","volume":"99","author":"T Burmeister","year":"2014","unstructured":"Burmeister T, Bartels G, Gr\u00f6ger D, et al. Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group. Haematologica. 2014;99:e23\u20135. https:\/\/doi.org\/10.3324\/haematol.2013.090720.","journal-title":"Haematologica"},{"key":"274_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.gene.2013.04.028","volume":"524","author":"Y Wang","year":"2013","unstructured":"Wang Y, Chen J, Li J, et al. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population. Gene. 2013;524:203\u20137. https:\/\/doi.org\/10.1016\/j.gene.2013.04.028.","journal-title":"Gene"},{"key":"274_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/MPH.0000000000001874","volume":"42","author":"YM Mosaad","year":"2020","unstructured":"Mosaad YM, El-Ziny MA, Darwish A, et al. IKZF1 rs4132601 and rs11978267 gene polymorphisms and acute lymphoblastic leukemia: relation to disease susceptibility and outcome. J Pediatr Hematol Oncol. 2020;42:420\u20138. https:\/\/doi.org\/10.1097\/MPH.0000000000001874.","journal-title":"J Pediatr Hematol Oncol"},{"key":"274_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.leukres.2013.04.022","volume":"37","author":"AM Linabery","year":"2013","unstructured":"Linabery AM, Blommer CN, Spector LG, Davies SM, Robison LL, Ross JA. ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group. Leuk Res. 2013;37:936\u201342. https:\/\/doi.org\/10.1016\/j.leukres.2013.04.022.","journal-title":"Leuk Res"},{"key":"274_CR26","doi-asserted-by":"publisher","unstructured":"Dong A, Wu YY, Rao YL, Li W, Tao R, Yan J.\u00a0Zhonghua Xue Ye Xue Za Zhi 2016;37:826-828. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2016.09.020.","DOI":"10.3760\/cma.j.issn.0253-2727.2016.09.020"},{"key":"274_CR27","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S1097-2765(02)00711-6","volume":"10","author":"N Harker","year":"2002","unstructured":"Harker N, Naito T, Cortes M, Hostert A, Hirschberg S, Tolaini M, et al. The CD8\u03b1 gene locus is regulated by the Ikaros family of proteins. Mol cell. 2002;10:1403\u201315.","journal-title":"Mol cell"},{"key":"274_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bcmd.2013.10.003","volume":"52","author":"CY Lin","year":"2014","unstructured":"Lin CY, Li MJ, Chang JG, et al. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan. Blood Cells Mol Dis. 2014;52:140\u20135. https:\/\/doi.org\/10.1016\/j.bcmd.2013.10.003.","journal-title":"Blood Cells Mol Dis"},{"key":"274_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12881-019-0900-1","volume":"20","author":"S Mahjoub","year":"2019","unstructured":"Mahjoub S, Chayeb V, Zitouni H, et al. IKZF1 genetic variants rs4132601 and rs11978267 and acute lymphoblastic leukemia risk in Tunisian children: a case-control study. BMC Med Genet. 2019;20:159. https:\/\/doi.org\/10.1186\/s12881-019-0900-1.","journal-title":"BMC Med Genet"},{"key":"274_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature06866","volume":"453","author":"CG Mullighan","year":"2008","unstructured":"Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008;453:110\u20134. https:\/\/doi.org\/10.1038\/nature06866.","journal-title":"Nature"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00274-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-025-00274-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00274-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T13:25:03Z","timestamp":1744377903000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-025-00274-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1186\/s43046-025-00274-2","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}